Medical Care
Global Women’s Health Therapeutics Market Research Report 2024
- Jan 20, 24
- ID: 15996
- Pages: 85
- Figures: 169
- Views: 79
Women's health in dermatology covers a vast array of topics that range from issues surrounding management of skin disease during pregnancy and lactation, available hormonal therapies for conditions such as acne and alopecia, hormonally driven conditions that are linked to dermatologic skin diseases such as polycystic, etc.
The global Women’s Health Therapeutics market was valued at US$ 103880 million in 2023 and is anticipated to reach US$ 150590 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Women’s Health Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women’s Health Therapeutics.
Report Scope
The Women’s Health Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Women’s Health Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women’s Health Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Pfizer, Inc.
Teva Pharmaceutical
F. Hoffmann-La Roche Ltd.
Merck and Co., Inc.
Bristol-Myers Squibb Company
AstraZeneca
Novartis AG
Eli Lilly and Company
GlaxoSmithKline plc
Mylan N.V.
Sanofi
Sun Pharmaceutical Industries Ltd.
CooperSurgical, Inc.
Segment by Type
Infection
Pregnancy
Oncology
Segment by Application
Below 20 Years Old
20~50 Years Old
Above 50 Years Old
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Women’s Health Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Women’s Health Therapeutics market was valued at US$ 103880 million in 2023 and is anticipated to reach US$ 150590 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Women’s Health Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women’s Health Therapeutics.
Report Scope
The Women’s Health Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Women’s Health Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women’s Health Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Pfizer, Inc.
Teva Pharmaceutical
F. Hoffmann-La Roche Ltd.
Merck and Co., Inc.
Bristol-Myers Squibb Company
AstraZeneca
Novartis AG
Eli Lilly and Company
GlaxoSmithKline plc
Mylan N.V.
Sanofi
Sun Pharmaceutical Industries Ltd.
CooperSurgical, Inc.
Segment by Type
Infection
Pregnancy
Oncology
Segment by Application
Below 20 Years Old
20~50 Years Old
Above 50 Years Old
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Women’s Health Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women’s Health Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infection
1.2.3 Pregnancy
1.2.4 Oncology
1.3 Market by Application
1.3.1 Global Women’s Health Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Below 20 Years Old
1.3.3 20~50 Years Old
1.3.4 Above 50 Years Old
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Women’s Health Therapeutics Market Perspective (2019-2030)
2.2 Women’s Health Therapeutics Growth Trends by Region
2.2.1 Global Women’s Health Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Women’s Health Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Women’s Health Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Women’s Health Therapeutics Market Dynamics
2.3.1 Women’s Health Therapeutics Industry Trends
2.3.2 Women’s Health Therapeutics Market Drivers
2.3.3 Women’s Health Therapeutics Market Challenges
2.3.4 Women’s Health Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women’s Health Therapeutics Players by Revenue
3.1.1 Global Top Women’s Health Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Women’s Health Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Women’s Health Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Women’s Health Therapeutics Revenue
3.4 Global Women’s Health Therapeutics Market Concentration Ratio
3.4.1 Global Women’s Health Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women’s Health Therapeutics Revenue in 2023
3.5 Women’s Health Therapeutics Key Players Head office and Area Served
3.6 Key Players Women’s Health Therapeutics Product Solution and Service
3.7 Date of Enter into Women’s Health Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Women’s Health Therapeutics Breakdown Data by Type
4.1 Global Women’s Health Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Women’s Health Therapeutics Forecasted Market Size by Type (2025-2030)
5 Women’s Health Therapeutics Breakdown Data by Application
5.1 Global Women’s Health Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Women’s Health Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Women’s Health Therapeutics Market Size (2019-2030)
6.2 North America Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Women’s Health Therapeutics Market Size by Country (2019-2024)
6.4 North America Women’s Health Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Women’s Health Therapeutics Market Size (2019-2030)
7.2 Europe Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Women’s Health Therapeutics Market Size by Country (2019-2024)
7.4 Europe Women’s Health Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Women’s Health Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Women’s Health Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Women’s Health Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Women’s Health Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Women’s Health Therapeutics Market Size (2019-2030)
9.2 Latin America Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Women’s Health Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Women’s Health Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women’s Health Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Women’s Health Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Women’s Health Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Women’s Health Therapeutics Introduction
11.1.4 Bayer AG Revenue in Women’s Health Therapeutics Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Detail
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Women’s Health Therapeutics Introduction
11.2.4 Pfizer, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.2.5 Pfizer, Inc. Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Detail
11.3.2 Teva Pharmaceutical Business Overview
11.3.3 Teva Pharmaceutical Women’s Health Therapeutics Introduction
11.3.4 Teva Pharmaceutical Revenue in Women’s Health Therapeutics Business (2019-2024)
11.3.5 Teva Pharmaceutical Recent Development
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Detail
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
11.5 Merck and Co., Inc.
11.5.1 Merck and Co., Inc. Company Detail
11.5.2 Merck and Co., Inc. Business Overview
11.5.3 Merck and Co., Inc. Women’s Health Therapeutics Introduction
11.5.4 Merck and Co., Inc. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.5.5 Merck and Co., Inc. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Detail
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Women’s Health Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Women’s Health Therapeutics Business (2019-2024)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Women’s Health Therapeutics Introduction
11.7.4 AstraZeneca Revenue in Women’s Health Therapeutics Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Women’s Health Therapeutics Introduction
11.8.4 Novartis AG Revenue in Women’s Health Therapeutics Business (2019-2024)
11.8.5 Novartis AG Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Detail
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Women’s Health Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Women’s Health Therapeutics Business (2019-2024)
11.9.5 Eli Lilly and Company Recent Development
11.10 GlaxoSmithKline plc
11.10.1 GlaxoSmithKline plc Company Detail
11.10.2 GlaxoSmithKline plc Business Overview
11.10.3 GlaxoSmithKline plc Women’s Health Therapeutics Introduction
11.10.4 GlaxoSmithKline plc Revenue in Women’s Health Therapeutics Business (2019-2024)
11.10.5 GlaxoSmithKline plc Recent Development
11.11 Mylan N.V.
11.11.1 Mylan N.V. Company Detail
11.11.2 Mylan N.V. Business Overview
11.11.3 Mylan N.V. Women’s Health Therapeutics Introduction
11.11.4 Mylan N.V. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.11.5 Mylan N.V. Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Women’s Health Therapeutics Introduction
11.12.4 Sanofi Revenue in Women’s Health Therapeutics Business (2019-2024)
11.12.5 Sanofi Recent Development
11.13 Sun Pharmaceutical Industries Ltd.
11.13.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.13.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.13.3 Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Introduction
11.13.4 Sun Pharmaceutical Industries Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.13.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.14 CooperSurgical, Inc.
11.14.1 CooperSurgical, Inc. Company Detail
11.14.2 CooperSurgical, Inc. Business Overview
11.14.3 CooperSurgical, Inc. Women’s Health Therapeutics Introduction
11.14.4 CooperSurgical, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.14.5 CooperSurgical, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women’s Health Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infection
1.2.3 Pregnancy
1.2.4 Oncology
1.3 Market by Application
1.3.1 Global Women’s Health Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Below 20 Years Old
1.3.3 20~50 Years Old
1.3.4 Above 50 Years Old
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Women’s Health Therapeutics Market Perspective (2019-2030)
2.2 Women’s Health Therapeutics Growth Trends by Region
2.2.1 Global Women’s Health Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Women’s Health Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Women’s Health Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Women’s Health Therapeutics Market Dynamics
2.3.1 Women’s Health Therapeutics Industry Trends
2.3.2 Women’s Health Therapeutics Market Drivers
2.3.3 Women’s Health Therapeutics Market Challenges
2.3.4 Women’s Health Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women’s Health Therapeutics Players by Revenue
3.1.1 Global Top Women’s Health Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Women’s Health Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Women’s Health Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Women’s Health Therapeutics Revenue
3.4 Global Women’s Health Therapeutics Market Concentration Ratio
3.4.1 Global Women’s Health Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women’s Health Therapeutics Revenue in 2023
3.5 Women’s Health Therapeutics Key Players Head office and Area Served
3.6 Key Players Women’s Health Therapeutics Product Solution and Service
3.7 Date of Enter into Women’s Health Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Women’s Health Therapeutics Breakdown Data by Type
4.1 Global Women’s Health Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Women’s Health Therapeutics Forecasted Market Size by Type (2025-2030)
5 Women’s Health Therapeutics Breakdown Data by Application
5.1 Global Women’s Health Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Women’s Health Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Women’s Health Therapeutics Market Size (2019-2030)
6.2 North America Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Women’s Health Therapeutics Market Size by Country (2019-2024)
6.4 North America Women’s Health Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Women’s Health Therapeutics Market Size (2019-2030)
7.2 Europe Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Women’s Health Therapeutics Market Size by Country (2019-2024)
7.4 Europe Women’s Health Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Women’s Health Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Women’s Health Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Women’s Health Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Women’s Health Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Women’s Health Therapeutics Market Size (2019-2030)
9.2 Latin America Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Women’s Health Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Women’s Health Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women’s Health Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Women’s Health Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Women’s Health Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Women’s Health Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Women’s Health Therapeutics Introduction
11.1.4 Bayer AG Revenue in Women’s Health Therapeutics Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Detail
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Women’s Health Therapeutics Introduction
11.2.4 Pfizer, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.2.5 Pfizer, Inc. Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Detail
11.3.2 Teva Pharmaceutical Business Overview
11.3.3 Teva Pharmaceutical Women’s Health Therapeutics Introduction
11.3.4 Teva Pharmaceutical Revenue in Women’s Health Therapeutics Business (2019-2024)
11.3.5 Teva Pharmaceutical Recent Development
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Detail
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
11.5 Merck and Co., Inc.
11.5.1 Merck and Co., Inc. Company Detail
11.5.2 Merck and Co., Inc. Business Overview
11.5.3 Merck and Co., Inc. Women’s Health Therapeutics Introduction
11.5.4 Merck and Co., Inc. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.5.5 Merck and Co., Inc. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Detail
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Women’s Health Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Women’s Health Therapeutics Business (2019-2024)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Women’s Health Therapeutics Introduction
11.7.4 AstraZeneca Revenue in Women’s Health Therapeutics Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Women’s Health Therapeutics Introduction
11.8.4 Novartis AG Revenue in Women’s Health Therapeutics Business (2019-2024)
11.8.5 Novartis AG Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Detail
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Women’s Health Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Women’s Health Therapeutics Business (2019-2024)
11.9.5 Eli Lilly and Company Recent Development
11.10 GlaxoSmithKline plc
11.10.1 GlaxoSmithKline plc Company Detail
11.10.2 GlaxoSmithKline plc Business Overview
11.10.3 GlaxoSmithKline plc Women’s Health Therapeutics Introduction
11.10.4 GlaxoSmithKline plc Revenue in Women’s Health Therapeutics Business (2019-2024)
11.10.5 GlaxoSmithKline plc Recent Development
11.11 Mylan N.V.
11.11.1 Mylan N.V. Company Detail
11.11.2 Mylan N.V. Business Overview
11.11.3 Mylan N.V. Women’s Health Therapeutics Introduction
11.11.4 Mylan N.V. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.11.5 Mylan N.V. Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Women’s Health Therapeutics Introduction
11.12.4 Sanofi Revenue in Women’s Health Therapeutics Business (2019-2024)
11.12.5 Sanofi Recent Development
11.13 Sun Pharmaceutical Industries Ltd.
11.13.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.13.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.13.3 Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Introduction
11.13.4 Sun Pharmaceutical Industries Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.13.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.14 CooperSurgical, Inc.
11.14.1 CooperSurgical, Inc. Company Detail
11.14.2 CooperSurgical, Inc. Business Overview
11.14.3 CooperSurgical, Inc. Women’s Health Therapeutics Introduction
11.14.4 CooperSurgical, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024)
11.14.5 CooperSurgical, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Women’s Health Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Infection
Table 3. Key Players of Pregnancy
Table 4. Key Players of Oncology
Table 5. Global Women’s Health Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Women’s Health Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Women’s Health Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Women’s Health Therapeutics Market Share by Region (2019-2024)
Table 9. Global Women’s Health Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Women’s Health Therapeutics Market Share by Region (2025-2030)
Table 11. Women’s Health Therapeutics Market Trends
Table 12. Women’s Health Therapeutics Market Drivers
Table 13. Women’s Health Therapeutics Market Challenges
Table 14. Women’s Health Therapeutics Market Restraints
Table 15. Global Women’s Health Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Women’s Health Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Women’s Health Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Therapeutics as of 2023)
Table 18. Ranking of Global Top Women’s Health Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Women’s Health Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Women’s Health Therapeutics Product Solution and Service
Table 22. Date of Enter into Women’s Health Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Women’s Health Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Women’s Health Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Women’s Health Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Women’s Health Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Women’s Health Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Women’s Health Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Women’s Health Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Women’s Health Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Women’s Health Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Women’s Health Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Women’s Health Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer AG Company Detail
Table 48. Bayer AG Business Overview
Table 49. Bayer AG Women’s Health Therapeutics Product
Table 50. Bayer AG Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Bayer AG Recent Development
Table 52. Pfizer, Inc. Company Detail
Table 53. Pfizer, Inc. Business Overview
Table 54. Pfizer, Inc. Women’s Health Therapeutics Product
Table 55. Pfizer, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Pfizer, Inc. Recent Development
Table 57. Teva Pharmaceutical Company Detail
Table 58. Teva Pharmaceutical Business Overview
Table 59. Teva Pharmaceutical Women’s Health Therapeutics Product
Table 60. Teva Pharmaceutical Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Teva Pharmaceutical Recent Development
Table 62. F. Hoffmann-La Roche Ltd. Company Detail
Table 63. F. Hoffmann-La Roche Ltd. Business Overview
Table 64. F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Product
Table 65. F. Hoffmann-La Roche Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 66. F. Hoffmann-La Roche Ltd. Recent Development
Table 67. Merck and Co., Inc. Company Detail
Table 68. Merck and Co., Inc. Business Overview
Table 69. Merck and Co., Inc. Women’s Health Therapeutics Product
Table 70. Merck and Co., Inc. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Merck and Co., Inc. Recent Development
Table 72. Bristol-Myers Squibb Company Company Detail
Table 73. Bristol-Myers Squibb Company Business Overview
Table 74. Bristol-Myers Squibb Company Women’s Health Therapeutics Product
Table 75. Bristol-Myers Squibb Company Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Bristol-Myers Squibb Company Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Women’s Health Therapeutics Product
Table 80. AstraZeneca Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Novartis AG Company Detail
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Women’s Health Therapeutics Product
Table 85. Novartis AG Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Eli Lilly and Company Company Detail
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Women’s Health Therapeutics Product
Table 90. Eli Lilly and Company Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Eli Lilly and Company Recent Development
Table 92. GlaxoSmithKline plc Company Detail
Table 93. GlaxoSmithKline plc Business Overview
Table 94. GlaxoSmithKline plc Women’s Health Therapeutics Product
Table 95. GlaxoSmithKline plc Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 96. GlaxoSmithKline plc Recent Development
Table 97. Mylan N.V. Company Detail
Table 98. Mylan N.V. Business Overview
Table 99. Mylan N.V. Women’s Health Therapeutics Product
Table 100. Mylan N.V. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 101. Mylan N.V. Recent Development
Table 102. Sanofi Company Detail
Table 103. Sanofi Business Overview
Table 104. Sanofi Women’s Health Therapeutics Product
Table 105. Sanofi Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 106. Sanofi Recent Development
Table 107. Sun Pharmaceutical Industries Ltd. Company Detail
Table 108. Sun Pharmaceutical Industries Ltd. Business Overview
Table 109. Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Product
Table 110. Sun Pharmaceutical Industries Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 111. Sun Pharmaceutical Industries Ltd. Recent Development
Table 112. CooperSurgical, Inc. Company Detail
Table 113. CooperSurgical, Inc. Business Overview
Table 114. CooperSurgical, Inc. Women’s Health Therapeutics Product
Table 115. CooperSurgical, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 116. CooperSurgical, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women’s Health Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Women’s Health Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Infection Features
Figure 4. Pregnancy Features
Figure 5. Oncology Features
Figure 6. Global Women’s Health Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Women’s Health Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Below 20 Years Old Case Studies
Figure 9. 20~50 Years Old Case Studies
Figure 10. Above 50 Years Old Case Studies
Figure 11. Women’s Health Therapeutics Report Years Considered
Figure 12. Global Women’s Health Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Women’s Health Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Women’s Health Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Women’s Health Therapeutics Market Share by Players in 2023
Figure 16. Global Top Women’s Health Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Women’s Health Therapeutics Revenue in 2023
Figure 18. North America Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Women’s Health Therapeutics Market Share by Region (2019-2030)
Figure 32. China Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bayer AG Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 47. Pfizer, Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 48. Teva Pharmaceutical Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 50. Merck and Co., Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 51. Bristol-Myers Squibb Company Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 53. Novartis AG Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 55. GlaxoSmithKline plc Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 56. Mylan N.V. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 57. Sanofi Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 58. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 59. CooperSurgical, Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Women’s Health Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Infection
Table 3. Key Players of Pregnancy
Table 4. Key Players of Oncology
Table 5. Global Women’s Health Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Women’s Health Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Women’s Health Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Women’s Health Therapeutics Market Share by Region (2019-2024)
Table 9. Global Women’s Health Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Women’s Health Therapeutics Market Share by Region (2025-2030)
Table 11. Women’s Health Therapeutics Market Trends
Table 12. Women’s Health Therapeutics Market Drivers
Table 13. Women’s Health Therapeutics Market Challenges
Table 14. Women’s Health Therapeutics Market Restraints
Table 15. Global Women’s Health Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Women’s Health Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Women’s Health Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Therapeutics as of 2023)
Table 18. Ranking of Global Top Women’s Health Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Women’s Health Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Women’s Health Therapeutics Product Solution and Service
Table 22. Date of Enter into Women’s Health Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Women’s Health Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Women’s Health Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Women’s Health Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Women’s Health Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Women’s Health Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Women’s Health Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Women’s Health Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Women’s Health Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Women’s Health Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Women’s Health Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Women’s Health Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Women’s Health Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Women’s Health Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Women’s Health Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer AG Company Detail
Table 48. Bayer AG Business Overview
Table 49. Bayer AG Women’s Health Therapeutics Product
Table 50. Bayer AG Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Bayer AG Recent Development
Table 52. Pfizer, Inc. Company Detail
Table 53. Pfizer, Inc. Business Overview
Table 54. Pfizer, Inc. Women’s Health Therapeutics Product
Table 55. Pfizer, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Pfizer, Inc. Recent Development
Table 57. Teva Pharmaceutical Company Detail
Table 58. Teva Pharmaceutical Business Overview
Table 59. Teva Pharmaceutical Women’s Health Therapeutics Product
Table 60. Teva Pharmaceutical Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Teva Pharmaceutical Recent Development
Table 62. F. Hoffmann-La Roche Ltd. Company Detail
Table 63. F. Hoffmann-La Roche Ltd. Business Overview
Table 64. F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Product
Table 65. F. Hoffmann-La Roche Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 66. F. Hoffmann-La Roche Ltd. Recent Development
Table 67. Merck and Co., Inc. Company Detail
Table 68. Merck and Co., Inc. Business Overview
Table 69. Merck and Co., Inc. Women’s Health Therapeutics Product
Table 70. Merck and Co., Inc. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Merck and Co., Inc. Recent Development
Table 72. Bristol-Myers Squibb Company Company Detail
Table 73. Bristol-Myers Squibb Company Business Overview
Table 74. Bristol-Myers Squibb Company Women’s Health Therapeutics Product
Table 75. Bristol-Myers Squibb Company Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Bristol-Myers Squibb Company Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Women’s Health Therapeutics Product
Table 80. AstraZeneca Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Novartis AG Company Detail
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Women’s Health Therapeutics Product
Table 85. Novartis AG Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Eli Lilly and Company Company Detail
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Women’s Health Therapeutics Product
Table 90. Eli Lilly and Company Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Eli Lilly and Company Recent Development
Table 92. GlaxoSmithKline plc Company Detail
Table 93. GlaxoSmithKline plc Business Overview
Table 94. GlaxoSmithKline plc Women’s Health Therapeutics Product
Table 95. GlaxoSmithKline plc Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 96. GlaxoSmithKline plc Recent Development
Table 97. Mylan N.V. Company Detail
Table 98. Mylan N.V. Business Overview
Table 99. Mylan N.V. Women’s Health Therapeutics Product
Table 100. Mylan N.V. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 101. Mylan N.V. Recent Development
Table 102. Sanofi Company Detail
Table 103. Sanofi Business Overview
Table 104. Sanofi Women’s Health Therapeutics Product
Table 105. Sanofi Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 106. Sanofi Recent Development
Table 107. Sun Pharmaceutical Industries Ltd. Company Detail
Table 108. Sun Pharmaceutical Industries Ltd. Business Overview
Table 109. Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Product
Table 110. Sun Pharmaceutical Industries Ltd. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 111. Sun Pharmaceutical Industries Ltd. Recent Development
Table 112. CooperSurgical, Inc. Company Detail
Table 113. CooperSurgical, Inc. Business Overview
Table 114. CooperSurgical, Inc. Women’s Health Therapeutics Product
Table 115. CooperSurgical, Inc. Revenue in Women’s Health Therapeutics Business (2019-2024) & (US$ Million)
Table 116. CooperSurgical, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women’s Health Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Women’s Health Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Infection Features
Figure 4. Pregnancy Features
Figure 5. Oncology Features
Figure 6. Global Women’s Health Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Women’s Health Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Below 20 Years Old Case Studies
Figure 9. 20~50 Years Old Case Studies
Figure 10. Above 50 Years Old Case Studies
Figure 11. Women’s Health Therapeutics Report Years Considered
Figure 12. Global Women’s Health Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Women’s Health Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Women’s Health Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Women’s Health Therapeutics Market Share by Players in 2023
Figure 16. Global Top Women’s Health Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Women’s Health Therapeutics Revenue in 2023
Figure 18. North America Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Women’s Health Therapeutics Market Share by Region (2019-2030)
Figure 32. China Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Women’s Health Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Women’s Health Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bayer AG Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 47. Pfizer, Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 48. Teva Pharmaceutical Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 50. Merck and Co., Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 51. Bristol-Myers Squibb Company Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 53. Novartis AG Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 55. GlaxoSmithKline plc Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 56. Mylan N.V. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 57. Sanofi Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 58. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 59. CooperSurgical, Inc. Revenue Growth Rate in Women’s Health Therapeutics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232